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Results
Experiment 1
Total & free plasma myostatin was lower in
females than in males (total p = 0.027), free
p = 0.015). An effect of gender is removed if
myostatin concentration is normalised to fat
free mass.
Total myostatin decreases with age,
independent of gender (p = 0.046). Free
myostatin does not (p = 0.134).
Total / free myostatin ratio and FLRG
concentration show no gender difference or
relationship to age.
Introduction
The aging process involves a loss of
muscle strength, quality and mass, and a
general increase in frailty. Losses occurs at
a predictable rate from ~30 years of age1.
Whilst aging and muscle loss is intrinsic to
the human condition, excessive loss of
muscle mass (sarcopenia) affects 5 – 13 %
of people 60 – 70 years of age and up to 50
% of those > 80 years of age, greatly
decreasing quality of life and increasing
mortality2. Chronic exercisers show
successful aging, i.e. a maintenance of
physical function 3.
In both healthy individuals and chronic
disease states, muscle mass is controlled
by the peptide hormone myostatin4.
Disagreement exists in the literature as to
the role of myostatin in aging and frailty5,6.
We aimed to explore the role of myostatin
in aging, hypothesising a) myostatin would
be increased with age, and b) lifelong
exercisers would show reduced myostatin
relative to non-exercisers. Here we present
preliminary results of this investigation.
Methods
Experiment 1 – Healthy participants (n =
83, 18 – 75 years; 36 male) were recruited.
After an overnight fast, resting metabolic
rate, resting heart rate and blood pressure,
fat free mass (BodPod), anthropometry,
grip strength and six minute walk time was
recorded.
Experiment 2 – Sedentary ([SED]; n=14;
64±6 years) and lifelong exercisers ([LEX];
n=10, 61±6 years) completed 6 weeks of
high intensity interval training (HIIT), with
venous serum collected pre- and post-
training.
Circulating total myostatin, free myostatin,
and follistatin-related gene (FLRG) were
quantified by ELISA.
For both experiment 1 and 2, here we
present preliminary results, with data
analysis ongoing.
Circulating myostatin is reduced with ageing in humans 
but not altered by short-term, high intensity training
Stepwise regression indicated age was best
predicted by systolic blood pressure, resting
metabolic rate and total myostatin (r2 =
0.362, p = 0.015), and not improved by the
addition of any other measures (table 1).
Experiment 2
No group (SED, LEX) × time (pre, post)
interaction on serum total myostatin
concentration (p = 0.649), nor a main effect
of time (p = 0.757) was noted. The main
effect of group (SED vs LEX) on total
myostatin was p = 0.083.
Discussion
Here we show three key results;
1) Decreased total myostatin peptide in
healthy individuals as age increases.
2) Total myostatin aids prediction of
chronical age.
3) Acute HIIT training does not alter total
myostatin in older individuals.
A counterintuitive decrease in total & free
myostatin is seen as individuals age. Total
myostatin may better reflect muscle mass;
the addition of other variables (FLRG, free
myostatin) do not contribute towards a
prediction of age.
No effect of an acute HIIT protocol was
seen on either group. Previous reports7
have demonstrated resistance training
reduces plasma myostatin in young
individuals. Either the HITT protocol is not
optimal for alterations in myostatin & thus
muscle mass, or the age of participants is
key. We are currently completing 3 year
follow up data on the SED and LEX
individuals to establish longitudinal changes
in this cohort.
Figure 1: Myostatin is found in plasma as a bioactive peptide
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No additional predictive efficacy – Blood pressure (diastolic), resting heart rate, height,
weight, body mass index, lean mass (%), lean mass (kg) fat free mass index, thigh
diameter, thigh subcutaneous fat thickness, grip strength (dominant hand) six minute
walk time, FLRG (pg.mL‐1), free myostatin (pg.mL‐1).
